Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI

J Nucl Med. 1997 Sep;38(9):1389-92.

Abstract

Of 10 patients with neuroblastoma who had both 123I-MIBG scintigraphy and MRI at diagnosis, four presented with bone marrow metastasis that was diagnosed by both imaging modalities and confirmed by bone marrow biopsy and smears. This report focuses on the follow up of the four patients with bone marrow metastasis. MIBG scintigraphy and MRI were concordant in two patients, a case of normalization and a case of relapse in the seventh dorsal vertebra confirmed by surgical biopsy. The last two patients presented a normalized MIBG scan for marrow infiltration after chemotherapy but persistent abnormal MRI signal of several vertebrae, suggesting marrow infiltration, up to 27 mo after the end of chemotherapy in one case. In the second patient, MRI bone marrow aspect returned to normal 4 mo after the end of chemotherapy. Bone marrow biopsy remained negative in these two MIBG-negative patients. These cases suggest that in presence of complete normalization of the MIBG scan after chemotherapy, the persistence of a hypointense signal on bone marrow on T1WI does not necessarily indicate persistence of disease but may be due to delayed normalization. Therefore, attention must be paid to the delay of signal normalization on MRI (which can be as long as more than 2 yr after the end of chemotherapy) in order to avoid false-positive interpretation.

Publication types

  • Case Reports

MeSH terms

  • 3-Iodobenzylguanidine
  • Bone Marrow Neoplasms / diagnosis
  • Bone Marrow Neoplasms / diagnostic imaging*
  • Bone Marrow Neoplasms / secondary*
  • Child
  • Child, Preschool
  • Humans
  • Iodine Radioisotopes*
  • Iodobenzenes*
  • Magnetic Resonance Imaging*
  • Male
  • Neuroblastoma / diagnosis
  • Neuroblastoma / diagnostic imaging*
  • Neuroblastoma / secondary*
  • Radionuclide Imaging

Substances

  • Iodine Radioisotopes
  • Iodobenzenes
  • 3-Iodobenzylguanidine